Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
PPH
26
HOLDINGS
42%
ALSO IN FTXH
FTXH
51
HOLDINGS
20%
ALSO IN PPH
SECTOR DRIFT (PPH minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 9.8% | 7.5% | 7.5% |
|
ELI LILLY & CO | 19.1% | 6.8% | 6.8% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% | 7.2% | 4.5% |
|
JOHNSON & JOHNSON | 4.2% | 7.3% | 4.2% |
|
ABBVIE INC | 3.9% | 6.8% | 3.9% |
PPH Overweight Relative to FTXH
|
ELI LILLY & CO | 12.2% |
 |
NOVARTIS AG-ADR | 10.9% |
 |
NOVO-NORDISK A/S-SPONS ADR | 4.9% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.8% |
 |
SANOFI-AVENTIS-ADR | 4.6% |
|
ASTRAZENECA PLC-SPONS ADR | 4.5% |
|
MCKESSON CORP | 4.2% |
|
CENCORA INC | 3.8% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 3.1% |
 |
TEVA PHARMACEUTICAL-SP ADR | 2.9% |
PPH Underweight Relative to FTXH
|
REGENERON PHARMACEUTICALS | -3.7% |
|
CARDINAL HEALTH INC | -3.6% |
|
GILEAD SCIENCES INC | -3.6% |
|
AMGEN INC | -3.5% |
|
BIOGEN IDEC INC | -3.4% |
|
VERTEX PHARMACEUTICALS INC | -3.4% |
|
UNITED THERAPEUTICS CORP | -3.2% |
|
JOHNSON & JOHNSON | -3.1% |
|
ABBVIE INC | -2.9% |
|
BRISTOL-MYERS SQUIBB CO | -2.7% |